ImmunityBio, Inc. earnings per share and revenue

IBRX earnings per share for the last quarter are -0.09 USD whereas the estimation was -0.20 USD which accounts for 55.00% surprise. Company revenue for the same period amounts to 7.55 M USD despite the estimated figure of 9.62 M USD. Estimated earnings per share for the next quarter are -0.13 USD, and revenue is expected to reach 17.50 M USD. Also watch annual changes over time to get a bigger picture of IBRX earnings per share and revenue dynamics.